Estimating the Impact of PrEP Regimens Containing Long-Acting Injectable Cabotegravir or Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine Among Men Who Have Sex with Men in the United States: Mathematical Modelling for HPTN 083
Year: 2022
Type: preprint
Source: SSRN Electronic Journal
DOI: 10.2139/ssrn.4120419
Institutions: Imperial College London, Medical Research Council, Fred Hutch Cancer Center, Georgia Department of Public Health, Centers for Disease Control and Prevention, Government of the United States of America, Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, San Francisco Department of Public Health, Instituto Nacional de Infectologia Evandro Chagas, University of California, Los Angeles
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4285247386
